跳至主要内容
临床试验/ISRCTN59731654
ISRCTN59731654终止未知

Efficacy of a novel pancreaticojejunostomy technique in preventing pancreatic leakage and hemorrhage after pancreaticoduodenectomy: protocol for a randomised controlled trial

Shenjing Hospital of China Medical University0 个研究点目标入组 390 人开始时间: 2019年12月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
390

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Periampullary tumors indicated by at least two imaging examinations or pathological biopsy before surgery
  • 2. =18 years of age
  • 3. Provision of written informed consent by patients or their legal guardians

排除标准

  • 1. Extensive tumor metastasis
  • 2. Abnormal blood coagulation
  • 3. Renal dysfunction (creatinine >250 µmol/L)
  • 4. Chronic liver disease
  • 5. History of radiation therapy
  • 6. American Society of Anesthesiologists (ASA) class IV-V
  • 7. Life expectancy <48 hours
  • 8. Lactating or pregnant women
  • 9. Participation in other drug clinical trials

研究者

发起方
Shenjing Hospital of China Medical University

相似试验